Last 15.20 INR
Change Today +0.05 / 0.33%
Volume 5.7K
AD On Other Exchanges
Symbol
Exchange
Mumbai
As of 5:11 AM 02/28/15 All times are local (Market data is delayed by at least 15 minutes).

aarey drugs & pharmaceut (AD) Snapshot

Open
15.40
Previous Close
15.15
Day High
15.70
Day Low
14.75
52 Week High
07/9/14 - 22.76
52 Week Low
03/7/14 - 9.44
Market Cap
255.6M
Average Volume 10 Days
5.0K
EPS TTM
0.17
Shares Outstanding
16.8M
EX-Date
--
P/E TM
90.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for AAREY DRUGS & PHARMACEUT (AD)

Related News

No related news articles were found.

aarey drugs & pharmaceut (AD) Related Businessweek News

No Related Businessweek News Found

aarey drugs & pharmaceut (AD) Details

Aarey Drugs & Pharmaceuticals Limited manufactures and trades in API/bulk drugs primarily in India. The company’s API products include metronidazole and metronidazole benzoate; and pharma products comprise 2-methyl-5-nitroimidazole and 1-methylimidazole. It also imports and distributes various industrial chemicals and solvents, including methanol, toluene, xylene, acetic acid (glacial), acetone, liquor ammonia, and IPA. The company was formerly known as Niharika Textiles & Chemicals Private Limited and changed its name to Aarey Drugs & Pharmaceuticals Limited in March 1993. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.

Founded in 1990

aarey drugs & pharmaceut (AD) Top Compensated Officers

Managing Director, Director, Member of Audit ...
Total Annual Compensation: 300.0K
Compensation as of Fiscal Year 2014.

aarey drugs & pharmaceut (AD) Key Developments

Aarey Drugs & Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Aarey Drugs & Pharmaceuticals Ltd. announced unaudited earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported net income from operations of INR 527.662 million against INR 583.387 million for the same period a year ago. Operating profit before interest was INR 3.833 million against INR 3.730 million a year ago. Profit from ordinary activities before tax was INR 1.530 million against INR 2.514 million a year ago. Net profit for the period was INR 1.530 million or INR 0.09 per basic and diluted share against INR 2.514 million or INR 0.15 per basic and diluted share a year ago. For the nine months, the company reported net income from operations of INR 1,362.512 million against INR 1,627.359 million for the same period a year ago. Operating profit before interest was INR 16.337 million against INR 15.147 million a year ago. Profit from ordinary activities before tax was INR 10.035 million against INR 14.514 million a year ago. Net profit for the period was INR 10.035 million or INR 0.60 per basic and diluted share against INR 13.014 million or INR 0.78 per basic and diluted share a year ago.

Aarey Drugs & Pharmaceuticals Ltd. Appoints Damiyanti P. Ghatalia as Woman Director

Aarey Drugs & Pharmaceuticals Ltd. announced that the Board of Directors of the company at its meeting held on February 14, 2015, the board has appointed Smt. Damiyanti P. Ghatalia as the Woman Director of the company.

Aarey Drugs & Pharmaceuticals Ltd., Board Meeting, Feb 14, 2015

Aarey Drugs & Pharmaceuticals Ltd., Board Meeting, Feb 14, 2015. Agenda: To consider quarterly results; and to consider appoint Smt. Damiyanti P. Ghatalia as the Woman Director of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AD:IN 15.20 INR +0.05

AD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AD.
View Industry Companies
 

Industry Analysis

AD

Industry Average

Valuation AD Industry Range
Price/Earnings 34.4x
Price/Sales 0.2x
Price/Book -- Not Meaningful
Price/Cash Flow 18.4x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AAREY DRUGS & PHARMACEUT, please visit www.aareydrugs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.